Jürgen Götz

Professor Jürgen Götz is the Foundation Chair of Dementia Research and Director of the Clem Jones Centre for Ageing and Dementia Research at the Queensland Brain Institute, University of Queensland. He holds an NHMRC Leadership Fellowship and leads the Ultrasound Team in dementia therapies. Previously, he was a Professor and Chair of Molecular Biology at the University of Sydney. His research focuses on Alzheimer’s disease mechanisms, including tau and amyloid-β pathologies, and innovative therapies like therapeutic ultrasound. He pioneered clinical trials of ultrasound-based treatments for dementia.

Education: PhD in Immunology (University of Basel), postdoctoral training at UCSF and Sandoz Ltd (Novartis), and a Dr. habil. from the University of Zurich.

Research Interests: Molecular mechanisms of neurodegeneration, tau protein dynamics, therapeutic ultrasound for brain disorders, and translational medicine. His lab develops non-invasive ultrasound techniques to enhance drug delivery and restore cognitive function.

Publications: Over 270 peer-reviewed articles, including high-impact journals like Science, Cell, and Lancet. Recent work emphasizes ultrasound’s role in clearing amyloid plaques and modulating tau pathology.

Awards: Highly Cited Researcher (Clarivate), FAHMS, GAICD, and the Lesleigh Green Endowed Chair. His work has generated over 27,800 citations (h-index 86).

Advising & Grants: Supervised numerous PhD candidates and leads grants in dementia and ultrasound therapies. Collaborates globally on clinical trials and preclinical models.

Labs/Teams: Directs the Clem Jones Centre and oversees the Götz Lab, focusing on dementia’s molecular basis and therapeutic innovations.